TY - JOUR
T1 - How a group-based occupational therapy program works in woman with fibromyalgia
T2 - A process evaluation of the ADAPT program
AU - von Bülow, Cecilie
AU - Wæhrens, Eva Ejlersen
AU - Andersen, Ulla
AU - Amris, Kirstine
AU - la Cour, Karen
N1 - Publisher Copyright: © 2023 Scandinavian Journal of Occupational Therapy Foundation.
PY - 2023
Y1 - 2023
N2 - Background: The ADAPT Program have improved activities of daily living (ADL) in women with fibromyalgia. To understand the functioning of the program, it is relevant to evaluate how program theory components are linked to outcomes (mechanisms) and how the randomised controlled trial (RCT) context, influenced delivery and outcomes Objective: To evaluate ADAPT in terms of dose, mechanisms of change and contextual factors. Material/Methods: Dose was recorded on the n = 21 participants receiving ADAPT in the IMPROvE trial (NCT01352052). A subsample of n = 16 attended one of three 2-hour focusgroups, evaluating mechanisms of change and contextual factors. Interview questions explored participants’ interaction with four program components, i.e. how the ‘client-centred approach’, ‘group-based peer-exchange format’, ‘teaching-learning strategies’ and ‘long-term program format’ triggered mechanisms facilitating/hindering outcomes. Moreover, how randomisation procedures influenced delivery and outcomes. Results: Attending a long-term educational peer-exchange program, in which participants experienced met by a health professional that legitimised difficulties, facilitated participants knowledge, insights and motivation for changing habits. With time and support, participants experienced increased acceptance of their situation and began to implement more effective ways to perform ADL tasks. Conclusions/Significance: Results support previous findings of improved ADL ability post-ADAPT and provide initial evidence to support the ADAPT Program theory.
AB - Background: The ADAPT Program have improved activities of daily living (ADL) in women with fibromyalgia. To understand the functioning of the program, it is relevant to evaluate how program theory components are linked to outcomes (mechanisms) and how the randomised controlled trial (RCT) context, influenced delivery and outcomes Objective: To evaluate ADAPT in terms of dose, mechanisms of change and contextual factors. Material/Methods: Dose was recorded on the n = 21 participants receiving ADAPT in the IMPROvE trial (NCT01352052). A subsample of n = 16 attended one of three 2-hour focusgroups, evaluating mechanisms of change and contextual factors. Interview questions explored participants’ interaction with four program components, i.e. how the ‘client-centred approach’, ‘group-based peer-exchange format’, ‘teaching-learning strategies’ and ‘long-term program format’ triggered mechanisms facilitating/hindering outcomes. Moreover, how randomisation procedures influenced delivery and outcomes. Results: Attending a long-term educational peer-exchange program, in which participants experienced met by a health professional that legitimised difficulties, facilitated participants knowledge, insights and motivation for changing habits. With time and support, participants experienced increased acceptance of their situation and began to implement more effective ways to perform ADL tasks. Conclusions/Significance: Results support previous findings of improved ADL ability post-ADAPT and provide initial evidence to support the ADAPT Program theory.
KW - Activities of daily living (ADL)
KW - adaptation
KW - behaviour change techniques taxonomy version 1
KW - chronic conditions
KW - chronic widespread pain
KW - contextual factors
KW - mechanisms of change
KW - medical research council framework (MRC)
KW - peer-exchange
KW - program theory
UR - https://www.scopus.com/pages/publications/85167622493
U2 - 10.1080/11038128.2023.2242380
DO - 10.1080/11038128.2023.2242380
M3 - Journal article
C2 - 37557901
SN - 1103-8128
VL - 30
SP - 1523
EP - 1540
JO - Scandinavian Journal of Occupational Therapy
JF - Scandinavian Journal of Occupational Therapy
IS - 8
ER -